DALLAS, May 01, 2018 -- Via OTC PR Wire – Puration, Inc. (USOTC:PURA) Today announced plans to produce a THC infused beverage in Canada in conjunction with a previously announced pending acquisition intended to establish a cannabis cultivation operation for the recreational marijuana market expected to be legalized nationwide in Canada this summer. The new THC infused beverage will expand Puration’s current cannabis infused beverage business. Last year, Puration introduced EVERx, a CBD infused sports water. The sales of EVERx yielded over a 60% gross margin as reported in the company’s 2017 annual report. The initial sales have won the interest of additional distributors to include a recently announced national distribution contract. Puration has designed a THC infused beverage and registered the name THCSavor. Package design is underway. Highlights of the THCSavor go-to-market plan are to be included in the upcoming shareholder presentation scheduled for, Thursday next week, on May 10th, to provide overall details on the Canadian business acquisition expected to be closed as early as the end of this week.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350


Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal
Middle East Conflict Impacts Australia and New Zealand Businesses
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Hugo Boss Beats Q1 Profit Expectations Despite Market Headwinds
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market
Intel Emerges as Key Contender in Apple’s Chip Manufacturing Strategy Shift
Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 



